Floragenex
Floragenex is a Beaverton, Oregon-based genomic sequencing service provider offering RAD-Seq, ddRAD, WGS, MethylRAD, RNA-Seq, and targeted sequencing to academic, government, and commercial customers across 26 countries, operating as a subsidiary of Sedia Biosciences.
- Company typePrivate
- Founded2007
- HeadquartersBeaverton, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Floragenex does
Floragenex is a privately held Oregon-based biotechnology company founded in 2007 that provides genomic DNA sequencing and bioinformatics services to academic, government, and commercial institutions across 26 countries. The company originated from the invention of RAD-Seq (Restriction site-associated DNA sequencing) at the University of Oregon in 2006 and operates as a wholly-owned subsidiary of Sedia Biosciences Corporation, with laboratories in Beaverton, OR.
The company's service portfolio spans reduced-representation sequencing (RAD-Seq, SBG/ddRAD-Seq), Whole Genome Sequencing (Illumina short-read and PacBio long-read), MethylRAD for epigenetic methylation analysis, RNA-Seq for transcriptomics, and Targeted Sequencing using GTseek's Genotyping by Thousands technology. These services run on Illumina NovaSeq 6000, Illumina MiSeq, and PacBio Sequel II instrumentation. Floragenex's proprietary bioinformatics pipeline handles SNP detection, variant annotation, population structure, GWAS, and integrates with established genomics tools (TASSEL, STACKS, PLINK). The firm has sequenced more than 350 unique plant, animal, and archaeal species and produced over 6 TB of data in 2022 alone. Through its parent Sedia Biosciences, Floragenex also distributes the Applied Biosystems AgriSeq genotyping panel product line globally.
Floragenex operates a professional services revenue model with quote-based, per-project pricing. Standard projects scale to 95 samples with a pilot option for as few as 8 samples. Go-to-market is consultative and direct, anchored by a website-based project planning tool and inbound contact, supported by educational content and scientific publications demonstrating credibility. Customer segments include academic and research institutions, commercial agriculture and breeding companies, and government and conservation agencies. Technology partnerships include KeyGene N.V. (licensed SBG/ddRAD-Seq protocol), the University of Oregon (RNA-Seq collaboration), GTseek LLC (targeted sequencing), and a 2025 co-exclusive global distribution agreement with Thermo Fisher Scientific for AgriSeq agri-genomics products.
Floragenex firmographics
Firmographics- Name
- Floragenex
- Legal name
- FLORAGENEX, INC.
- Website
- https://floragenex.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Floragenex is a Beaverton, Oregon-based genomic sequencing service provider offering RAD-Seq, ddRAD, WGS, MethylRAD, RNA-Seq, and targeted sequencing to academic, government, and commercial customers across 26 countries, operating as a subsidiary of Sedia Biosciences.
- Ownership category
- akta.pro rank
Floragenex industry classification
Industry- Product category
- Genomic Sequencing Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)
- akta.pro secondary industries
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Biotechnology & Gene-Edited Trait Development (AFAGAIAG)
Keywords
Where Floragenex is headquartered
LocationHeadquarters
- HQ city
- Beaverton
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Floragenex business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain
Revenue model
- Genomic Sequencing Services: Service-based revenue from providing DNA sequencing services including RAD-Seq, ddRAD-Seq, WGS, RNA-Seq, methylRAD, and Targeted Sequencing to academic, government, and commercial institutions. Pricing is quote-based per project.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Pilot project option available for smaller projects with as few as 8 samples |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Floragenex product offering
Product offeringCore offering
Floragenex provides genomic technologies, analysis, and project collaboration to academic, government, and commercial institutions worldwide. The company delivers end-to-end DNA sequencing services including RAD-Seq, SBG/ddRAD-Seq, Whole Genome Sequencing, MethylRAD, RNA-Seq, and Targeted Sequencing, leveraging Illumina NovaSeq 6000, Illumina MiSeq, and PacBio Sequel II platforms. Services span sample consultation, DNA extraction guidance, library preparation, sequencing, bioinformatics analysis, and reporting, with a focus on non-model species and reduced-representation sequencing approaches that work without reference genomes.
Product overview
Floragenex provides genomic technologies and project collaboration services to academic, government, and commercial institutions worldwide. The company offers a portfolio of DNA sequencing services including RAD-Seq (Restriction site-associated DNA sequencing), SBG/ddRAD-Seq (Sequence-based genotyping/double digest RAD), WGS (Whole Genome Sequencing), MethylRAD (epigenetic methylation sequencing), RNA-Seq (transcriptome analysis), and Targeted Sequencing. These services are powered by partnerships with technology providers (KeyGene, University of Oregon, GTSeek LLC) and include bioinformatics analysis and consulting. The company also distributes the Applied Biosystems™ AgriSeq™ product line through its parent company Sedia Biosciences Corporation.
Differentiator
Problem solved
Functional benefit
Products and services
- RAD-Seq
Quantifiable outcome
- Produced over 6 terabytes of genomic data in 2022 alone
- +3 more outcomes
Companies that use Floragenex
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Floragenex technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Floragenex partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Sedia Biosciences CorporationcoreFloragenex is a subsidiary of Sedia Biosciences Corporation. Sedia provides testing services including HIV incidence testing, COVID-19 whole genome sequencing, and additional DNA sequencing through the Floragenex brand.
- GenoScreenminorGenoScreen offers scientists expertise in genomic technologies and bioinformatics, including molecular microbiology, targeted metagenomics, genome sequencing and assembly, and microsatellite identification.
- KeyGene N.V.coreKeyGene is a research company developing and applying technology innovation for crop improvement. Floragenex uses KeyGene's licensed SBG/ddRAD-Seq protocol for their sequencing services.
- GTseek LLCcoreGTseek develops cutting-edge methods and products for genotyping services. Floragenex partners with GTseek to deliver targeted sequencing services using Genotyping by Thousands technology and Nate's Plates.
- Genomics and Cell Characterization Core Facility (GC3F), University of OregonminorGC3F supports scientific research at the University of Oregon by providing access to genomics instrumentation and offering in-house sequencing sample prep services.
- Thermo Fisher ScientificcoreSedia Biosciences (Floragenex parent) is a global authorized distributor for Thermo Fisher Scientific's AgriSeq agri genomics products under a co-exclusive distribution agreement. Sedia markets, sells, and supports AgriSeq products globally (excluding US embargoed countries) and can manufacture custom 'Sedia Panels' using Thermo Fisher primer materials.
- University of OregoncoreFloragenex originated in 2006 at the University of Oregon with the invention of RAD-Seq. RNA-Seq services are powered by University of Oregon. The company continues to partner with UO for various research and service collaborations.
Scale indicators6 records
Expansion highlights5 records
Floragenex competitors and assessment
Company assessmentDirect peers
- GENEWIZ (Azenta Life Sciences): GENEWIZ provides NGS services including RAD-Seq-style reduced-representation sequencing, WGS, RNA-Seq, and targeted sequencing with integrated bioinformatics — a near-identical service mix to Floragenex, serving the same academic and commercial research customer base.
- KeyGene N.V. KeyGene is an agrigenomics research company that developed the SBG/ddRAD-Seq protocol that Floragenex licenses and offers commercially — both companies compete in crop improvement genomics for breeding customers, and KeyGene is also a licensor to Floragenex, making it a uniquely intertwined peer.
- GenoScreen: GenoScreen offers genomic technologies and bioinformatics services including targeted metagenomics and genome sequencing — Floragenex lists GenoScreen as a partner/collaborator, and both serve European academic and applied genomics customers with comparable service menus.
- LGC Biosearch Technologies: LGC Biosearch Technologies provides genomics services and genotyping-by-sequencing tools for agricultural and breeding applications — overlapping directly with Floragenex's agricultural customer segment and offering competing targeted sequencing products.
Emerging players
- CD Genomics: CD Genomics is an NGS services provider offering RAD-Seq, WGS, RNA-Seq, and de novo assembly with bioinformatics — a smaller-scale, service-only peer that competes with Floragenex for non-model organism and agricultural genomics customers globally.
- Rapid Genomics: Rapid Genomics specializes in high-throughput targeted genotyping and GBS (genotyping-by-sequencing) for agriculture and breeding applications — a focused emerging competitor in Floragenex's reduced-representation sequencing niche.
Broad incumbents
- BGI Genomics: BGI Genomics is one of the world's largest sequencing services providers, offering WGS, RNA-Seq, and a wide range of genomics solutions globally — competing with Floragenex on price-per-sample and capacity, though focused more on clinical and high-throughput human/clinical genomics.
- Eurofins Genomics: Eurofins Genomics is one of the largest global genomic services providers, offering DNA sequencing, genotyping, and bioinformatics to academic and commercial customers — directly competing with Floragenex for the same sequencing-service wallet share but at substantially greater scale and breadth.
- Novogene Corporation: Novogene is a leading global NGS services provider offering WGS, RNA-Seq, RAD-Seq, and bioinformatics at high volume with competitive pricing — directly comparable to Floragenex on services and target customers but with much greater sequencing capacity and geographic footprint.
Regional players
- University of Oregon GC3F Core Facility: The GC3F Genomics and Cell Characterization Core at the University of Oregon provides sequencing sample prep and library services for academic researchers — Floragenex's RNA-Seq service is "powered by" UO, and GC3F serves as both a regional peer and a partner/feed for Floragenex.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Floragenex social profiles
Digital presenceFloragenex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Floragenex leadership team
Management profileNumber of profiles
Profiles1 record
Floragenex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Floragenex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Floragenex
What does Floragenex do?
Floragenex provides genomic technologies, analysis, and project collaboration to academic, government, and commercial institutions worldwide. The company delivers end-to-end DNA sequencing services including RAD-Seq, SBG/ddRAD-Seq, Whole Genome Sequencing, MethylRAD, RNA-Seq, and Targeted Sequencing, leveraging Illumina NovaSeq 6000, Illumina MiSeq, and PacBio Sequel II platforms. Services span sample consultation, DNA extraction guidance, library preparation, sequencing, bioinformatics analysis, and reporting, with a focus on non-model species and reduced-representation sequencing approaches that work without reference genomes.
Is Floragenex a public or private company?
Floragenex is a private company. It is classified as corporate owned and is currently operating.
When was Floragenex founded?
Floragenex was founded in 2007. It employs 1 to 10 people.
Where is Floragenex based?
Floragenex is headquartered in Beaverton, United States, in the North America region.
How does Floragenex make money?
One revenue line is on record: genomic Sequencing Services.
Who are Floragenex's main competitors?
Direct peers on record are GENEWIZ (Azenta Life Sciences), KeyGene N.V., GenoScreen and LGC Biosearch Technologies. Emerging players are CD Genomics and Rapid Genomics. Broad incumbents are BGI Genomics, Eurofins Genomics and Novogene Corporation. University of Oregon GC3F Core Facility is listed as a regional player.
Does Floragenex have an API?
No public API is recorded for Floragenex.
What industry is Floragenex in?
Floragenex's product category is Genomic Sequencing Services. Its primary akta.pro industry code is HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services, with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 541714 and its SIC code is 8731.